Easton Pharmaceuticals Announces the Launching of Hempstral SA, a New Hemp Based Anti Ageing Product & Reaches Marketing Deve...
February 27 2014 - 08:51AM
Marketwired
Easton Pharmaceuticals Announces the Launching of Hempstral SA, a
New Hemp Based Anti Ageing Product & Reaches Marketing Develop
and Distribution Agreement With HempLifeToday.com
TORONTO, ON--(Marketwired - Feb 27, 2014) - Easton
Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical
company that owns, designs, develops, and markets an array of
topically-delivered drugs and therapeutic / cosmetic healthcare
products, today announces its has designed and launched its new
Hemp based product, Hempstral SA, and has reached an agreement with
Hemp Life Today, LLC, a wholly owned subsidiary of Global Links
Corp. Hemp Life Today will assist in developing a marketing and
distribution program as well as both companies jointly developing a
new line of innovative Hemp based products to be marketed on the
HempLifeToday.com website, for US and global distribution.
This agreement between Hemp Life Today, LLC and Easton
Pharmaceuticals will allow both companies to be better positioned
and place them at the forefront of developing, marketing and
worldwide distribution of Hemp based and other type of products
utilizing the HempLifeToday.com website. The first Hemp product
will be introduced at the Total Health Show in April with the
showcasing of Easton's newly developed Hempstral SA, an anti ageing
skin moisturizer product designed by Easton pharmaceuticals to
combat and prevent premature ageing and sun damaged skin. Hempstral
SA consists of high quality hemp oil, which can now be legally
obtained from US based producers following changes in federal and
state laws. Hempstral SA will be transdermally delivered through
skin tissue using Easton's pharmaceuticals transdermal delivery
matrix and formulations, which are patented and / or patent
pending, utilized in various other products. Other Hemp based and
traditional type products are expected to be introduced which will
involve the expertise of Easton Pharmaceuticals to design products,
and Hemp Life Today to effectively market, distribute and drive
sales.
"We are very excited with our new relationship entered into
between Easton pharmaceuticals and Hemp Life Today. We look forward
to featuring these amazing new Hemp based products on our site,"
stated Tim Zorn, President of HempLifeToday.com. With Hempstral SA
and other subsequent products, both companies will be tapping into
each other's expertise. Easton will design products, while Hemp
Life Today will provide branding, marketing and distribution."
Carla Pepe, corporate secretary and marketing director of Easton
Pharmaceuticals, commented, "We at Easton Pharmaceuticals are
looking forward to be working with Hemp Life Today to utilize their
marketing program to ultimately drive sales for Hempstral SA and
other subsequent products."
Hempstral SA is to be introduced in April at the Total health
Show, held in Toronto on April 2, 3 and 4 along with VIORRA and its
new wound healing and bed sore product, anticipated to be
officially unveiled prior to the Total Health Show.
In other news, Easton Pharmaceuticals has replaced its current
website contractor and hired the services of another website and
branding consultant to revamp its website including corporate
logo's and logo's of various other products. Additional updates on
all of its Medical Marijuana initiatives, its ongoing negotiations,
and its discussions with an expected manufacturing agreement in
Mexico for Viorra to be shortly announced or as they become
available.
For More Information Visit:
http://www.ashleybiomedical.com &
http://www.eastonpharma.com
For More Information On Global Links Corp. /
HempLifeToday.com Visit
http://www.HempLifeToday.com
Safe Harbor This news release may contain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (The "Act"). In particular, when used in the
preceding of discussion, the words "anticipate," "pleased," "plan,"
"confident that," "believe," "expect," "possible" or "intent to"
and similar conditional expressions are intended to identify
forward-looking statements within the meaning of the Act and are
subject to the safe harbor created by the Act. Such statements are
subject to certain risks and uncertainties and actual results could
differ materially from those expressed in any of the
forward-looking statements. Such risks and uncertainties include,
but are not limited to, market conditions, general acceptance of
the company's products and technologies, competitive factors, the
ability to successfully complete additional or adequate financing,
government approvals or changes to proposed laws and other risks
and uncertainties further stated in the company's financial reports
and filings.
Contact: Carla Pepe Easton Pharmaceuticals Inc. Tel: +1(416)
619-0291 Tel: +1(347) 284-0192 email: info@ashleybiomedical.com
email: info@lamindustries.com
Easton Pharmaceuticals (CE) (USOTC:EAPH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Easton Pharmaceuticals (CE) (USOTC:EAPH)
Historical Stock Chart
From Mar 2023 to Mar 2024